{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:39:33Z","timestamp":1784194773417,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2017,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.bbmt.2009.06.008","type":"journal-article","created":{"date-parts":[[2009,8,9]],"date-time":"2009-08-09T04:20:44Z","timestamp":1249791644000},"page":"1296-1305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Interferon Gamma 13-CA-Repeat Homozygous Genotype and a Low Proportion of CD4+ Lymphocytes Are Independent Risk Factors for Cytomegalovirus Reactivation with a High Number of Copies in Hematopoietic Stem Cell Transplantation Recipients"],"prefix":"10.1016","volume":"15","author":[{"given":"Emilia","family":"Jaskula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Dlubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Bogunia-Kubik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mlynarczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2009.06.008_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.exphem.2005.11.012","article-title":"Human cytomegalovirus infection of cells of hematopoietic origin: HCMV-induced immunosuppression, immune evasion, and latency","volume":"34","author":"Bego","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbmt.2003.10.007","volume":"10","author":"Fraser","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.06.008_bib3","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.4049\/jimmunol.180.10.6923","article-title":"Blockade of virus infection by human CD4+ T cells via a cytokine relay network","volume":"180","author":"Davis","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","article-title":"Regulation of interferon-gamma during innate and adaptive immune responses","volume":"96","author":"Schoenborn","year":"2007","journal-title":"Adv Immunol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0198-8859(96)00271-6","article-title":"HLA class II\u2013associated polymorphism of interferon-\u03b3 production implications for HLA\u2013disease association","volume":"53","author":"Petrovsky","year":"1997","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1744-313X.2008.00796.x","article-title":"Genetic factors predicting IFN-gamma generation potential in patients with sarcoidosis and after haematopoietic stem cell transplantation","volume":"35","author":"Lange","year":"2008","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.bbmt.2009.06.008_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0198-8859(00)00167-1","article-title":"A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production","volume":"61","author":"Pravica","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2370.1999.00122.x","article-title":"In vitro production of interferon-gamma correlates with CA repeat polymorphism in the human IFN-GAMMA gene","volume":"26","author":"Pravica","year":"1999","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.bbmt.2009.06.008_bib9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/rheumatology\/41.5.518","article-title":"Genetically determined interferon-gamma production influences the histological phenotype of lupus nephritis","volume":"41","author":"Miyake","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbmt.2009.06.008_bib10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/sj.gene.6363775","article-title":"Interferon-gamma polymorphisms in systemic lupus erythematosus","volume":"2","author":"Lee","year":"2001","journal-title":"Genes Immunol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00251-005-0783-5","article-title":"Functional IFNG polymorphism in intron 1 in association with an increased risk to promote sporadic breast cancer","volume":"57","author":"Saha","year":"2005","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bbmt.2009.06.008_bib12","series-title":"Haematopoietic Stem Cell Transplantation\u2014ESH\/EBMT Handbook","first-page":"592","author":"Apperley","year":"2008"},{"key":"10.1016\/j.bbmt.2009.06.008_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bmt.1704581","article-title":"Lack of IFN-gamma 2\/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGVHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation","volume":"34","author":"Mlynarczewska","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.06.008_bib14","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/JCM.38.7.2536-2542.2000","article-title":"Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation","volume":"38","author":"Machida","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbmt.2009.06.008_bib16","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/sj.leu.2403105","article-title":"Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin\u2013based reduced intensity preparative regimen","volume":"17","author":"Mohty","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2009.06.008_bib17","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1182\/blood.V99.12.4357","article-title":"High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-lH in delaying immune reconstitution","volume":"99","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.06.008_bib18","first-page":"1055","article-title":"Bone marrow risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation","volume":"40","author":"Bjorklund","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.06.008_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.bmt.1704528","article-title":"Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection","volume":"34","author":"Kim","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.06.008_bib20","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1182\/blood.V99.8.3050","article-title":"Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants","volume":"99","author":"Ljungman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.06.008_bib21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1086\/378413","article-title":"Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients","volume":"188","author":"Cortez","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2009.06.008_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/sj.bmt.1703227","article-title":"CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR","volume":"28","author":"Schulenburg","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.06.008_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1399-3062.2006.00183.x","article-title":"Oral valganciclovir as preemptive therapy for cytomegalovirus infection post\u2013allogeneic stem cell transplantation","volume":"9","author":"Busca","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2009.06.008_bib24","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2002-11-3472","article-title":"Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation","volume":"102","author":"Hakki","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.06.008_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1399-3062.2007.00235.x","article-title":"Predictors for persistent cytomegalovirus reactivation after T-cell\u2013depleted allogeneic hematopoietic stem cell transplantation","volume":"9","author":"Almyroudis","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2009.06.008_bib26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.humimm.2004.02.012","article-title":"Cytomegalovirus (CMV)-specific cellular immune responses","volume":"65","author":"Harari","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/00007890-200203270-00025","article-title":"The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease","volume":"73","author":"Razonable","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2009.06.008_bib28","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1128\/JCM.41.8.3840-3845.2003","article-title":"Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay","volume":"41","author":"Mengelle","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib29","first-page":"1544","article-title":"Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes and plasma of human immunodeficiency virus\u2013infected subjects","volume":"178","author":"Boivin","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bbmt.2009.06.008_bib30","first-page":"392","article-title":"Compromised interferon gamma (IFN-gamma) production in the elderly to both acute and latent viral antigen stimulation: contribution to the immune risk phenotype?","volume":"13","author":"Ouyang","year":"2002","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.bbmt.2009.06.008_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bmt.1705507","article-title":"Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation","volume":"38","author":"Avetisyan","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2009.06.008_bib32","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-06-0626","article-title":"Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response","volume":"12","author":"Brandt","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2009.06.008_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jso.21130","article-title":"Inverse relationship between the length of the EGFR CA repeat polymorphism in lung carcinoma and protein expression of EGFR in the carcinoma","volume":"98","author":"Suzuki","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1677\/jme.0.0250085","article-title":"Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines","volume":"25","author":"Beilin","year":"2000","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.HYP.36.2.187","article-title":"CA-repeat polymorphism in intron 1 of HSD11B2: effects on gene expression and salt sensitivity","volume":"36","author":"Agarwal","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.bbmt.2009.06.008_bib36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.amjhyper.2007.02.019","article-title":"A polymorphic GT short tandem repeat affecting beta-ENaC mRNA expression is associated with low-renin essential hypertension","volume":"20","author":"Gonz\u00e1lez","year":"2007","journal-title":"Am J\u00a0Hypertens"},{"key":"10.1016\/j.bbmt.2009.06.008_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1006\/cyto.1997.0224","article-title":"Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis","volume":"9","author":"Seitzer","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.bbmt.2009.06.008_bib38","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbmt.2009.06.008_bib39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.177.2.557","article-title":"An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles","volume":"177","author":"Wilson","year":"1993","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2009.06.008_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.imlet.2003.11.005","article-title":"Combined association between IFN-gamma 3,3 homozygosity and DRB1\u221703 in L\u00f6fgren's syndrome patients","volume":"91","author":"Wysoczanska","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.bbmt.2009.06.008_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2249.1995.tb03713.x","article-title":"Presence of mRNA for interferon-gamma (IFN-gamma) in blood mononuclear cells is associated with an active stage I sarcoidosis","volume":"100","author":"Swider","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib42","first-page":"425","article-title":"Recipient interferon-gamma 3\/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"90","author":"Bogunia-Kubik","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2009.06.008_bib43","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4049\/jimmunol.173.2.910","article-title":"Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease","volume":"173","author":"Puliaev","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2141.2005.05875.x","article-title":"The presence of IFNG 3\/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation","volume":"132","author":"Bogunia-Kubik","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00251-006-0184-4","article-title":"Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians","volume":"59","author":"Abbott","year":"2007","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bbmt.2009.06.008_bib46","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V98.5.1594","article-title":"Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation","volume":"98","author":"Cavet","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.06.008_bib47","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.humimm.2005.02.003","article-title":"IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease","volume":"66","author":"Karabon","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib48","first-page":"5","article-title":"Transforming growth factor-beta1 codon 10 polymorphism is associated with acute GVHD after allogenic BMT in Iranian population","volume":"12","author":"Noori-Daloii","year":"2007","journal-title":"Ann Transplant"},{"key":"10.1016\/j.bbmt.2009.06.008_bib49","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/157488806776956850","article-title":"Non-HLA gene polymorphisms and the outcome of allogeneic hemato-poietic stem cell transplantation","volume":"1","author":"Bogunia-Kubik","year":"2006","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1016\/j.bbmt.2009.06.008_bib50","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-3083.2007.02021.x","article-title":"IL-2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation","volume":"66","author":"Viel","year":"2007","journal-title":"Scand J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib51","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1365-2141.2001.02519.x","article-title":"Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis","volume":"112","author":"Craddock","year":"2001","journal-title":"Br J\u00a0Haematol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib52","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2002-10-3263","article-title":"Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis","volume":"102","author":"Ljungman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.06.008_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.beha.2006.09.003","article-title":"Risk assessment in haematopoietic stem cell transplantation: viral status","volume":"20","author":"Ljungman","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2009.06.008_bib54","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.1182\/blood-2009-02-203307","article-title":"Impact of donor CMV status on viral infection and reconstitution of multi-function CMV-specific T-cells in CMV-positive transplant recipients","volume":"113","author":"Zhou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2009.06.008_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1399-3062.2009.00372.x","article-title":"Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation","volume":"11","author":"Fisher","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2009.06.008_bib56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1743-422X-6-4","article-title":"Feeling manipulated: cytomegalovirus immune manipulation","volume":"6","author":"Miller-Kittrell","year":"2009","journal-title":"Virol J"},{"key":"10.1016\/j.bbmt.2009.06.008_bib57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1462-5822.2004.00425.x","article-title":"Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system","volume":"6","author":"Mocarski","year":"2004","journal-title":"Cell Microbiol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109002900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879109002900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:34:05Z","timestamp":1761057245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879109002900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1083879109002900"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.06.008","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon Gamma 13-CA-Repeat Homozygous Genotype and a Low Proportion of CD4+ Lymphocytes Are Independent Risk Factors for Cytomegalovirus Reactivation with a High Number of Copies in Hematopoietic Stem Cell Transplantation Recipients","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2009.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}